E-DRUG Archives (by date)

• Thread Index

February 27, 1998
• E-DRUG: Terfenadine withdrawn from the U.S. market
  • From: srahmad@essential.org
February 25, 1998
• E-DRUG: Consumers' Guide to Safe, Cost-effective Meds
  • From: ra@usp.org
• E-DRUG: Consumers' Guide to Safe, Cost-effective Medicin (cont'd)
  • From: Dennis Ross-Degnan <drossdeg@warren.med.harvard.edu>
• E-DRUG: Consumers' Guide to Safe, Cost-effective Medicines (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: U.S. FDA on Anti-Acne Drug
  • From: srahmad@essential.org
• E-DRUG: Consumers' Guide to Safe, Cost-effective Medicines
  • From: Elaine Cosser <emcosser@wn.apc.org>
• E-DRUG: new TB discussion list
  • From: Ian Smith <iansmith@mos.com.np>
February 24, 1998
• E-DRUG: Dipyrone (cont'd)
  • From: Mary Couper <couperm@who.ch>
February 23, 1998
• E-DRUG: International Society for Pharmacoepidemiology
  • From: Alec Walker <amwalker@episun1.harvard.edu>
• E-DRUG: Dipyrone (cont'd)
  • From: Leo Offerhaus <lo@euronet.nl>
• E-DRUG: Mefloquine price wars in South Africa
  • From: Andrew Jamieson <aj.plett@pixie.co.za>
• E-DRUG: Dipyrone
  • From: "F. Cankat Tulunay" <F.Cankat.Tulunay@pallas.dialup.ankara.edu.tr>
February 22, 1998
• E-DRUG: Use of Isotretinoin in pregnancy
  • From: Jerome Sclafer <jeromjet@easynet.fr>
• E-DRUG: National Library of Medicine (cont'd)
  • From: "Joan D. Levin" <jdlevin@interaccess.com>
February 20, 1998
• E-DRUG: WHO Plan To Halt Antibiotic Resistance
  • From: srahmad@essential.org
• E-DRUG: HIV trials in developing countries (cont'd)
  • From: David Gilbert <cndgilb@kehf.org.uk>
• E-DRUG: POPP PKPD Draft discussion paper
  • From: David Addison <addisond@dia-swap.org.au>
February 19, 1998
• E-DRUG: HIV trials in developing countries
  • From: srahmad@essential.org
February 17, 1998
• E-DRUG: Use of drugs in sports (cont'd)
  • From: Rodrigo Rosa <sysop@bol.healthnet.org>
• E-DRUG: Vacancy
  • From: HLSP Ltd <hlsp@compuserve.com>
• E-DRUG: Insulin stability (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
• E-DRUG: Antidiarrhoeal Ercefuryl (cont'd)
  • From: Agnes.Vitry@usa.healthnet.org, MaLAM <avitry@amh.adelaide.edu.au>
• E-DRUG: Safety of Fexofenadine (cont'd)
  • From: Leesette Turner <hamis@iafrica.com>
February 16, 1998
• E-DRUG: Use of Oxygen in the Home Environment
  • From: Tony Odendaal <SYSMAN@COMED.PWV.GOV.ZA>
• E-DRUG: Use of drugs in sports (cont'd)
  • From: Dzulkifli Abdul Razak <dzul@prn.usm.my>
February 15, 1998
• E-DRUG: Many NSAID users who bleed ...... (cont'd)
  • From: Tim Dodd <timdodd@brain.net.pk>
• E-DRUG: Inappropriate combinations with corticosteroids (cont'd)
  • From: Yupp Javroongrit <yuppjav@health.moph.go.th>
February 14, 1998
• E-DRUG: Use of drugs in sports (cont'd)
  • From: Graeme Vernon <vernon@austin.unimelb.edu.au>
February 13, 1998
• E-DRUG: Many NSAID users who bleed ...... (cont'd)
  • From: Alec Walker <amwalker@episun1.harvard.edu>
• E-DRUG: Use of drugs in sports (cont'd)
  • From: Kirsten Myhr <myhr@online.no>
• E-DRUG: Course "Pharmacoepidemiology: The Cuban Model"
  • From: CDF Cuba <cdf@infomed.sld.cu>
• E-DRUG: Many NSAID users who bleed don't know when to stop
  • From: srahmad@essential.org
• E-DRUG: Safety of Fexofenadine (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
February 12, 1998
• E-DRUG: Safety of Fexofenadine ( Allegra)
  • From: Carmen Cano <6086888@mail.cosapidata.com.pe>
• E-DRUG: Isomers and omeprazole (cont'd)
  • From: Randy Trinkle <rtrinkle@skylite.datanet.ab.ca>
• E-DRUG: South African Health Review 1997, Chapter 10: Drug Policy
  • From: "Halima Rooplall" <halima@healthlink.org.za>
• E-DRUG: Use of drugs in sports
  • From: Nyaroo Eric Achoki <kdep@ken.healthnet.org>
• E-DRUG: Changes at National Library of Medicine (cont'd)
  • From: "Joan D. Levin" <jdlevin@interaccess.com>
• E-DRUG: Antidiarrhoeal Ercefuryl (cont'd)
  • From: Jerome Sclafer <jeromjet@easynet.fr>
• E-DRUG: Bolar Roche exemption (cont'd)
  • From: <Joel.Lexchin@usa.healthnet.org> joel.lexchin@utoronto.ca
February 11, 1998
• E-DRUG: Changes at National Library of Medicine
  • From: "Joan D. Levin" <jdlevin@interaccess.com>
• E-DRUG: Isomers and omeprazole
  • From: Kirsten Myhr <myhr@online.no>
• E-DRUG: Bolar Roche exemption (cont'd)
  • From: Michael Davis <Michael.Davis@law.csuohio.edu>
• E-DRUG: U.S. FDA Warning on Pain killer
  • From: srahmad@essential.org
• E-DRUG: Antidiarrhoeal Ercefuryll (cont'd)
  • From: Tim Dodd <timdodd@brain.net.pk>
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: Barbara Mintzes <bmintzes@compuserve.com>
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: John Urquhart <urquhart@netcom.com>
• E-DRUG: Bolar Roche provision (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: Bolar Roche provision?
  • From: Bada Pharasi <hall032@hltrsa.pwv.gov.za>
February 10, 1998
• E-DRUG: U.S. FDA Warning on Pain killer
  • From: srahmad@essential.org
• E-DRUG: Ethics of AIDS Drug Trials
  • From: srahmad@essential.org
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: Barbara Mintzes <bmintzes@compuserve.com>
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: John Urquhart <urquhart@netcom.com>
• E-DRUG: Antidiarrhoeal Ercefuryll (cont'd)
  • From: Tim Dodd <timdodd@brain.net.pk>
• E-DRUG: Use of hyoscine to promote the first stage of labour
  • From: Moses Chisale <chisalem@server.whoafr.org>
• E-DRUG: Ethics on research in developing countries
  • From: procaare@usa.healthnet.org
• E-DRUG: RFI: Drug Companies and Social Action Programs
  • From: "Sheila J. Madhani" <ncihaids@ncihaids.org>
February 09, 1998
• E-DRUG: U.S. FDA issues Warning on Astemizole
  • From: srahmad@essential.org
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: John Urquhart <urquhart@netcom.com>
• E-DRUG: Antidiarrhoeal Ercefuryll
  • From: Truls Eriksen <ERIKSENT@who.org.ph>
• E-DRUG: Norgestrel in contraceptive pills (cont'd)
  • From: Marcel Reyners <reynersm@dts.mg>
February 08, 1998
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: Barbara Mintzes <bmintzes@compuserve.com>
February 07, 1998
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: John Urquhart <urquhart@netcom.com>
February 06, 1998
• E-DRUG: Gender differences in drug utilization (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: Sedation of children pre-op (cont'd)
  • From: Randy Trinkle <rtrinkle@skylite.datanet.ab.ca>
• E-DRUG: Mail-order drug delivery (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: Nomination Director General WHO (cont'd)
  • From: Hilbrand Haak <haakh@compuserve.com>
• E-DRUG: Generic drugs versus brand names
  • From: Mark Campbell <Mark.Campbell@newcastle.ac.uk>
• E-DRUG: WHO-EB Resolution on Revised Drug Strategy
  • From: Hai@hai.antenna.nl
• E-DRUG: Conference announcement
  • From: Mullerova Hana <mulleroh@faf.cuni.cz>
• E-DRUG: Diluent of vaccines (contd)
  • From: FBA@compuserve.com
• E-DRUG: FTAA - Health Care and IP (contd)
  • From: James Love <love@cptech.org>
• E-DRUG: Gender differences in drug utilization
  • From: Alec Walker <amwalker@episun1.harvard.edu>
• E-DRUG: Nomination Director General WHO (cont'd)
  • From: TSUTANI Kiichiro <tsutani.cph@mri.tmd.ac.jp>
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: Leo Offerhaus <lo@euronet.nl>
February 05, 1998
• E-DRUG: Sedation of children pre-op (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• E-DRUG: Mail-order drug delivery (contd)
  • From: Kirsten Myhr <myhr@online.no>
• E-DRUG: Prescrire International at lower price
  • From: international@prescrire.org
• E-DRUG: Sedation of children pre-op
  • From: Tim Dodd <timdodd@brain.net.pk>
• E-DRUG: FTAA - Health Care and IP
  • From: James Love <love@cptech.org>
• E-DRUG: Norgestrel and combined contraceptive pills (contd)
  • From: Kirsten Myhr <myhr@online.no>
February 04, 1998
• E-DRUG: U.S. FDA says generic drugs as good as brand names
  • From: srahmad@essential.org
February 02, 1998
• E-DRUG: King's Fund Breakfast Seminar (London, UK)
  • From: David Gilbert <cndgilb@kehf.org.uk>
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: John Urquhart <urquhart@netcom.com>
• E-DRUG: Ketotifen
  • From: Leo Offerhaus <lo@euronet.nl>
February 01, 1998
• E-DRUG: Ketotifen (cont'd)
  • From: Gaut Gadeholt <gaut@online.no>
• E-DRUG: GMP and how to get the reliable suppliers (cont'd)
  • From: Gaut Gadeholt <gaut@online.no>
• E-DRUG: Norgestrel and combined contraceptive pills (cont'd)
  • From: Gaut Gadeholt <gaut@online.no>